Bernina BioInvest

What is Bernina BioInvest?

Bernina BioInvest is a healthcare-focused investment fund operating under the umbrella of the Swiss Biotech Association. Engaged in the funding ecosystem for advancements in the Biotech, HealthTech & Fitness, Medical Devices & Hospital Services, Healthcare & Wellness, and Pharmaceutical & Medicine industries, Bernina BioInvest primarily assists early-stage companies.

They offer a vital source of financing with investment minimums starting at $100,000, a maximum threshold of $5,000,000, and a sweet spot in funding positioning at $1,500,000. Bernie BioInvest is specialized in seed funding, playing a crucial role in supporting nascent companies that demonstrate high potential for growth and innovation in the healthcare sector.

They emphasize creating value by investing in and nurturing companies that are likely to address unmet medical needs, drive technological advancements, and contribute to the overall betterment of healthcare outcomes. At the same time, they leverage the network and resources provided by the Swiss Biotech Association to secure favorable conditions and access to an array of resources including talents, novel technologies, and financial resources.

Furthermore, Bernina BioInvest benefits from a synergy with a wide spectrum of industry stakeholders, which includes not only investment opportunities but also joint ventures and partnerships that help to propel the Swiss biotech industry forward. By participating on the board of the Swiss Biotech Association, the investors at Bernina BioInvest actively contribute to the strategic direction and support of the biotech industry in Switzerland, showcasing their deep commitment to this innovation-driven sector.